Kolexia
Pere Verge Denis Gastro-entérologie
Pere Verge Denis
Gastro-entérologie
Centre Hospitalier Saint Joseph Saint Luc
Lyon, France
46 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs du pancréas Infections sur cathéters Adénomes Tumeurs du foie Thromboembolie Neuropathies périphériques Métastase tumorale

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Souquet Jean Christophe
Souquet Jean Christophe
Hôpital La Croix-Rousse, Lyon, France
Pasquion Audrey
Pasquion Audrey
Centre Hospitalier Saint Joseph Saint Luc, Lyon, France
Phelip Jean-Marc
Phelip Jean-Marc
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France

Industries

Voir plus
Mayoly Spindler
2 collaboration(s)
Dernière en 2023
Abbvie
1 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Journal of the National Comprehensive Cancer Network : JNCCN   16 décembre 2023
Adapted physical activity in patients (Pts) with advanced pancreatic cancer (APACaP): Results from a prospective national randomized GERCOR trial.
2022 ASCO Annual Meeting I   02 juin 2022
Vidéo : « La foi à l’épreuve de la pandémie » par le p. Denis Malvy
Youtube @ Orthodoxie.com   01 avril 2022
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
Frontiers in pharmacology   04 novembre 2021
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer: Randomized Phase II/III Trial Comparing Folririnox Association [Oxaliplatin / Irinotecan / LV5FU2] Versus Gemcitabine in First Line of Chemotherapy in Metastatics Pancreas Cancers Patients
Essai Clinique (Unicancer)   05 mars 2021
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study.
Journal of clinical medicine   27 juillet 2020
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.
Journal of geriatric oncology   22 avril 2020
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
Oncotarget   05 juin 2018
Adenoma detection with blue-water infusion colonoscopy: a randomized trial.
Endoscopy   11 avril 2017
Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016